Tucatinib in Combination With Oral Etoposide andTrastuzumab in Patients With Metastatic HER2+ Breast Cancer
Tucatinib in Combination With Oral Etoposide andTrastuzumab in Patients With Metastatic HER2+ Breast Cancer
Recruiting · NCT05955170 · Registry updated 2025-03-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Tucatinib in Combination With Oral Etoposide andTrastuzumab in Patients With Metastatic HER2+ Breast Cancer | HER2-positive Breast Cancer | Recruiting | Phase 2 | 2025-03-27 | NCT05955170 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Institut Curie | 48 |
| Seagen Inc. | 31 |
13 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre CARIO-Hôpital Privé des Côtes d'Armor (HPCA) | Plérin | France | 1 |
| Centre François Baclesse | Caen | France | 40 |
| Centre Georges-François Leclerc | Dijon | France | 15 |
| Centre Jean Perrin | Clermont-Ferrand | France | 1 |
| Centre Oscar Lambret | Lille | France | 73 |
| CHU Amiens Picardie-Site Sud | Amiens | France | 1 |
| Hopital Saint-Louis Ap-Hp Senopole | Paris | France | 1 |
| Hôpital privé du Confluent | Nantes | France | 13 |
| Institut Curie | Saint-Cloud | France | 19 |
| Institut Curie | Paris | France | 81 |
| Institut du Cancer Montpellier | Montpellier | France | 2 |
| Institut Sainte Catherine | Avignon | France | 9 |
| Oncopole Claudius Regaud | Toulouse | France | 17 |